The company said, “Based on all information available to date, the Company remains confident in its 2026 Individual MA pricing and benefit design, including the expectation that it will double individual MA pre-tax margin in 2026 (excluding Stars), and believes it is positioned to return to membership growth in 2026.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana says 20% of members in 4 stars or above MA plans for 2026
- Humana says ‘not satisfied’ with 2026 Medicare Advantage star ratings
- Humana still expects return to top quartile MA star ratings in 2027
- Humana price target lowered to $280 from $330 at BofA
- Trump Trade: White House announces drug pricing deal with Pfizer